{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:43:29Z","timestamp":1794473009255,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      Patients presenting with acute coronary syndrome are administered a P2Y\n                      <jats:sub>12<\/jats:sub>\n                      inhibitor and aspirin before coronary catheterization to prevent further myocardial injury from thrombosis. Guidelines recommend a standard waiting period between the time patients are administered dual antiplatelet therapy (DAPT) and elective cardiac surgery. Since 25% to 30% of the population may be considered nonresponders to clopidogrel, platelet function testing can be utilized for timing of surgery and to assess bleeding risks. The extent to which a standard waiting period or platelet function testing is used across centers is not established, representing an important opportunity to standardize practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study from 2011 to 2020 using data from the Maryland Cardiac Surgical Quality Initiative, a consortium of all 10 hospitals in the state performing cardiac surgery. The proportion of patients administered DAPT within 5 days of surgery was examined by hospital over the time period. Mixed-effects multivariable logistic regressions were used to examine the association of preoperative DAPT with ischemic and bleeding outcomes. Centers were surveyed on use or nonuse of preoperative platelet function testing, and bleeding outcomes were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      There was significant heterogeneity of preoperative DAPT usage across centers ranging from 2% to 54% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). DAPT within 5 days of isolated coronary artery bypass grafting (CABG) was associated with higher odds of reoperation for bleeding (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.19\u20132.01;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .001), &gt;2 units of red blood cells (RBCs) transfused (OR, 1.62; 95% CI, 1.44\u20131.81;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), and &gt;2 units of non-RBCs transfused (OR, 1.79; 95% CI, 1.60\u20132.00;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). In the 5 hospitals using preoperative platelet function testing to guide timing of surgery, there were greater odds for DAPT within 5 days (OR, 1.33; 95% CI, 1.22\u20131.45;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), fewer RBCs &gt;2 units transfusions (22% vs 33%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), and non-RBCs &gt;2 units (17% vs 28%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) transfusions within DAPT patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>There is significant variability in DAPT usage within 5 days of CABG between hospital centers. Preoperative platelet function testing may allow for earlier timing of surgery for those on DAPT without increased bleeding risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005964","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T12:00:30Z","timestamp":1650024030000},"page":"567-575","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Center Variation in Use of Preoperative Dual Antiplatelet Therapy and Platelet Function Testing at the Time of Coronary Artery Bypass Grafting in Maryland"],"prefix":"10.1213","volume":"135","author":[{"given":"Nadia B.","family":"Hensley","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Promise T.","family":"Ariyo","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari D.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene S.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Joseph Robert Whitman","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Ad","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland"},{"name":"Division of Cardiac Surgery, Adventist Health Care White Oak Medical Center, Silver Spring, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Stephen","family":"Metkus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Maryland Cardiac Surgical Quality Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"152","author":"Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization.","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11239-017-1529-6","article-title":"Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.","volume":"44","author":"Bazemore","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.","volume":"37","author":"Hansson","year":"2016","journal-title":"Eur Heart J"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jocs.12312","article-title":"P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting.","volume":"29","author":"Yu","year":"2014","journal-title":"J Card Surg"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/clc.22357","article-title":"Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: verify pre-op TIMI 45\u2013a pilot study.","volume":"38","author":"Reed","year":"2015","journal-title":"Clin Cardiol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.118.035160","article-title":"Is there a role for preoperative platelet function testing in patients undergoing cardiac surgery during antiplatelet therapy?","volume":"138","author":"Mahla","year":"2018","journal-title":"Circulation"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.athoracsur.2021.03.033","article-title":"STS\/SCA\/AmSECT\/SABM update to the clinical practice guidelines on patient blood management.","volume":"112","author":"Tibi","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.athoracsur.2012.07.086","article-title":"2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations.","volume":"94","author":"Ferraris","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","article-title":"2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery.","volume":"32","author":"Boer","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.athoracsur.2017.06.062","article-title":"Less is more: results of a statewide analysis of the impact of blood transfusion on coronary artery bypass grafting outcomes.","volume":"105","author":"Crawford","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.athoracsur.2016.05.109","article-title":"Variation in red blood cell transfusion practices during cardiac operations among centers in Maryland: results from a state quality-improvement collaborative.","volume":"103","author":"Magruder","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.athoracsur.2018.10.004","article-title":"The society of thoracic surgeons adult cardiac surgery database: 2019 update on outcomes and quality.","volume":"107","author":"D\u2019Agostino","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jtcvs.2017.09.092","article-title":"Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery.","volume":"155","author":"Mori","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jtcvs.2015.08.066","article-title":"Dual antiplatelet therapy use by Canadian cardiac surgeons.","volume":"150","author":"Yanagawa","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jacc.2021.01.015","article-title":"Platelet reactivity in patients with acute coronary syndromes awaiting surgical revascularization.","volume":"77","author":"Nakashima","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250502","first-page":"50","article-title":"Estimating the risk of complications related to re-exploration for bleeding after adult cardiac surgery: a systematic review and meta-analysis.","volume":"41","author":"Biancari","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.athoracsur.2020.02.028","article-title":"Reoperative cardiac surgery is a risk factor for long-term mortality.","volume":"110","author":"Bianco","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","article-title":"Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.","volume":"5","author":"Mahla","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/ALN.0000000000003541","article-title":"Platelet function testing in patients on antiplatelet therapy before cardiac surgery.","volume":"133","author":"Mahla","year":"2020","journal-title":"Anesthesiology"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.thromres.2009.06.024","article-title":"Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery.","volume":"124","author":"Alstr\u00f6m","year":"2009","journal-title":"Thromb Res"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2010.03.108","article-title":"Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery.","volume":"56","author":"Kwak","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","article-title":"Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines.","volume":"91","author":"Ranucci","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jtcvs.2013.06.029","article-title":"Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.","volume":"146","author":"Rosengart","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/j.jvca.2013.12.010","article-title":"Thromboelastograph with Platelet Mapping predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting.","volume":"28","author":"Chowdhury","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/bja\/aeu315","article-title":"Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery.","volume":"113","author":"Ranucci","year":"2014","journal-title":"Br J Anaesth"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aew189","article-title":"Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study.","volume":"117","author":"Malm","year":"2016","journal-title":"Br J Anaesth"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/icvts\/ivy336","article-title":"Postoperative platelet function is associated with severe bleeding in ticagrelor-treated patients.","volume":"28","author":"Bj\u00f6rklund","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:29:13Z","timestamp":1786112953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005964","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,15]]}}}